Analysts have cut their estimates for Dr Reddy's sales in the fiscal year ending March 2017 by an average of Rs500 crore Dr. Reddy's dropped 8.5%... ...http://www.livemint.com/Companies/7wgbxkIi45p16PAmkmhN7M/US-FDA-warning-poses-threat-to-Dr-Reddys-revenue-outlook.html
Pharmaceutical companies are having a bad time on the bourses. With the US Food and Drugs Administration (FDA) becoming stricter on products... ...http://smartinvestor.business-standard.com/market/Marketnews-350307-Marketnewsdet-Alkem_dares_pharma_sentiment_with_an_IPO_but_will_it_succeed.htm
The shares of Sun Pharmaceutical Industries gained as much as 4.5% on Thursday after the company on Tuesday announced that its subsidiaries were... ...http://www.dnaindia.com/money/report-sun-pharma-drops-wind-energy-plan-shares-rise-over-4-2149131
MUMBAI: Taro Pharmaceutical Industries, a global subsidiary of India's largest drug maker Sun Pharmaceutical, has dropped its plan to invest in a... ...http://economictimes.indiatimes.com/markets/stocks/news/taro-pharma-drops-plan-to-invest-in-suzlons-us-power-project/articleshow/49914342.cms
In an interview with , Dipan Mehta, Member BSE & NSE, shares his short-term outlook on the market. The expert also shares his top investment ideas.... ...http://economictimes.indiatimes.com/opinion/interviews/gas-stocks-can-be-good-trading-bets-but-they-cant-be-a-part-of-core-holding-dipan-mehta/articleshow/49869994.cms
Projector on rent in vadodara,...